P1.03-15 TMS Reduced Gefitinib Resistance in NSCLCs via Suppressing MAPK/Akt/Bcl-2 Pathway by Upregulation of miR-345 and miR-498

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.696
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search